| Singapore state investment fund Temasek Holdings Private Ltd has increased its stake in NASDAQ-listed Regeneron Pharmaceuticals by 116.77 per cent, based on its latest Q1 2016 regulatory filing with the SEC, purchasing 68,062 shares as Regeneron’s stock declined 30.22 per cent while US stock markets rallied.
The consideration for the enlarged stake is $24.5 million. Regeneron Pharmaceuticals Inc – which has a market capitalisation of $42.51 billion – focuses on commercialising medicines for eye diseases, high low-density lipoprotein cholesterol and a rare inflammatory condition, and has product candidates in development in other areas of unmet medical need which include oncology, rheumatoid arthritis (RA), asthma, atopic dermatitis, pain and infectious diseases...............................................Full Article: Source
|